Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of CBC Pharma IPO.
March 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechJune 17, 2020 3:30:00 AM
The scale of the IPO � which is the largest in the US this year across all industrial sectors � reflects Royalty Pharma�s position as the largest player in the niche area of pharmaceutical ...
Published by : pharmaphorumMarch 21, 2024 8:18:00 PM
Commissions do not affect our editors' opinions or evaluations. Remember IPOs? A cavalcade of companies went public during the peak of the Covid-19 pandemic in 2020 and 2021 as the stock market ...
Published by : ForbesMay 12, 2020 3:30:00 AM
LTRN believes it can better stratify patient populations for improved trial results for previously failed Phase 3 trials drug candidates. LTRN believes it can better stratify patient populations ...
Published by : TheStreet.comApril 16, 2024 4:08:28 PM
Digital marketing company Ibotta ( IBTA) is looking to raise about $551M in an upsized initial public offering. The company and some of existing shareholders plan to sell a combined 6.56M shares in an ...
Published by : Seeking Alpha on MSNApril 18, 2024 10:36:00 AM
Walmart -backed digital marketing company Ibotta will likely raise $577.3 million at a valuation of $2.67 billion, after pricing its initial public offering on Wednesday.
Published by : ReutersJanuary 29, 2015 3:13:00 PM
If the biotech bull market hasn't reached 11 on the absurdity meter quite yet, the Flex Pharma FLKS IPO gets us close. If the biotech bull market hasn't reached 11 on the absurdity meter quite yet ...
Published by : TheStreet.comMay 8, 2023 9:53:00 AM
The IPO was issued at Rs 1,080 with a price range of Rs 1,026-1,080 per share, and a lot of Mankind Pharma comprised of 13 shares. The IPO received an overwhelming response from investors ...
Published by : MSNAugust 13, 2020 4:56:00 AM
CBC is serious about protecting sources. We are also serious about providing you the most secure and confidential way to reach us to share sensitive information. In this day and age, internet ...
Published by : CBC.caApril 18, 2024 4:40:00 PM
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company�s ...
Published by : Seeking AlphaJanuary 27, 2021 10:37:00 PM
Performance cookies help us understand how well the CBC Kids sites are working. We need them to find out what errors are happening on the sites and to create statistical reports of our audiences.
Published by : CBC.caThe IPO Shares of Chandra Bhagat Pharma Ltd IPO are proposed to list on Friday, February 14, 2020 at BSE SME. The public issue of CBC Pharma IPO was opened on Jan 31, 2020 and closed for subscription on Feb 6, 2020. CBC Pharma IPO Listing Date and Information:
| Listing Date | Friday, February 14, 2020 |
| BSE Script Code | 542934 |
| NSE Symbol | |
| Listing In | |
| ISIN | INE07QQ01016 |
| Issue Price | Rs 51 Per Equity Share |
| Face Value | Rs 10 Per Equity Share |
The allotment status of Chandra Bhagat Pharma Ltd IPO is now available online. The public issue of CBC Pharma IPO was open on Jan 31, 2020 and closed for subscription on Feb 6, 2020. The equity shares of the company to be list at BSE SME.
Chandra Bhagat Pharma Ltd is entering in the capital market with an IPO of 2,000,000 Equity Shares of Rs 10 aggregating up to Rs 10.20 Crore. The price for the issue has been set at Rs 51 Per Equity Share.
Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market.
The issue opens on Jan 31, 2020 and closes for subscription on Feb 6, 2020. The equity shares of the company to be list at BSE SME.
The issue of Chandra Bhagat Pharma Ltd opens on Jan 31, 2020 and closes for subscription on Feb 6, 2020. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 51 Per Equity Share.
The CBC Pharma IPO is proposed to open on January 31, 2020. The IPO application ends on February 6, 2020.
Retail investors can apply in the retail or non-institutional investor category from January 31, 2020 to February 6, 2020. The CBC Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The CBC Pharma IPO will open for subscription on January 31, 2020. The public issue will close on February 6, 2020.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
